CN111153875A - Gamma valerolactone and method for preparing gamma valerolactone by utilizing levulinate - Google Patents

Gamma valerolactone and method for preparing gamma valerolactone by utilizing levulinate Download PDF

Info

Publication number
CN111153875A
CN111153875A CN202010010195.3A CN202010010195A CN111153875A CN 111153875 A CN111153875 A CN 111153875A CN 202010010195 A CN202010010195 A CN 202010010195A CN 111153875 A CN111153875 A CN 111153875A
Authority
CN
China
Prior art keywords
gamma valerolactone
reaction
levulinate
based metal
metal alloy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010010195.3A
Other languages
Chinese (zh)
Inventor
霍志保
任德章
王敬一
赵策
张拿慧
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Ocean University
Original Assignee
Shanghai Ocean University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Ocean University filed Critical Shanghai Ocean University
Priority to CN202010010195.3A priority Critical patent/CN111153875A/en
Publication of CN111153875A publication Critical patent/CN111153875A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32Oxygen atoms
    • C07D307/33Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form

Abstract

The invention provides gamma valerolactone and a method for preparing gamma valerolactone by utilizing levulinate, which comprises the following steps: reacting levulinic acid ester, a framework type copper-based metal alloy catalyst and deionized water under the condition of hydrogen at the temperature of 140-180 ℃ for 1-3 h; carrying out solid-liquid separation after the reaction, collecting a liquid-phase product, and purifying to obtain gamma valerolactone; the framework type copper-based metal alloy catalyst is prepared by soaking copper-aluminum alloy in an aqueous solution of alkali, wherein the aqueous solution of the alkali is a sodium hydroxide aqueous solution with the weight percent of 20 +/-1 percent; the method uses the cheap framework type copper-based metal alloy catalyst, uses the green solvent deionized water, has mild reaction conditions, and adopts renewable biomass derivatives as reaction raw materials, so that the obtained gamma valerolactone has high yield, can be widely used as a green solvent, a biofuel and the like, and further provides a new way for the utilization of renewable biomass energy.

Description

Gamma valerolactone and method for preparing gamma valerolactone by utilizing levulinate
Technical Field
The invention belongs to the technical field of energy chemical industry, and particularly relates to gamma valerolactone and a method for preparing gamma valerolactone by utilizing levulinate.
Background
The excessive dependence and consumption of fossil energy sources such as coal, oil and natural gas has caused human beings to face serious energy and environmental crisis. There is much interest in developing and utilizing renewable clean energy sources such as solar energy, wind energy, tidal energy, and biomass energy. The biomass energy has the advantages of low pollution, wide distribution, rich sources, large reserves and the like. The effective utilization of biomass resources can alleviate the human need for fossil energy to some extent. Gamma valerolactone is an important biofuel, can be used as an environment-friendly solvent with various functions, and has huge demand. Gamma valerolactone is generally prepared by catalytic hydrogenation of biomass derivative levulinate, and conventionally, precious metal catalysts (such as ruthenium, platinum, palladium, iridium and the like) and organic solvents are often required to be used, so that the operation cost is increased, and therefore, the development and the use of cheap and commercialized metal catalysts and cheap green solvents are of great significance for the production of the gamma valerolactone.
Disclosure of Invention
Aiming at the defects in the prior art, the invention aims to provide a method for preparing gamma valerolactone by utilizing levulinate.
It is a second object of the present invention to provide gamma valerolactone as described above.
In order to achieve the above purpose, the solution of the invention is as follows:
a method for preparing gamma valerolactone from levulinate ester, comprising the steps of:
reacting levulinic acid ester, a framework type copper-based metal alloy catalyst and deionized water under the condition of hydrogen at the temperature of 140-180 ℃ for 1-3 h; and carrying out solid-liquid separation after the reaction, collecting a liquid-phase product, and purifying to obtain gamma valerolactone.
The framework type copper-based metal alloy catalyst is prepared by soaking copper-aluminum alloy (active component) in an aqueous alkali solution, wherein the aqueous alkali solution is a 20 +/-1 wt% aqueous sodium hydroxide solution.
As a further improvement of the invention, the temperature of the aqueous alkali solution is 0-10 ℃.
As a further improvement of the invention, the soaking time is 1.5-4.5 h.
As a further improvement of the invention, the pressure of the hydrogen is 1-5 MPa.
In a further improvement of the present invention, the levulinic acid ester is selected from one or more of methyl levulinate, ethyl levulinate, propyl levulinate and butyl levulinate.
Gamma valerolactone, which is prepared by the method.
Due to the adoption of the scheme, the invention has the beneficial effects that:
firstly, the gamma valerolactone is synthesized by using a biomass derivative levulinate raw material, the levulinate can be prepared from biomass resource lignocellulose (from plants widely existing in the nature), fossil energy is not consumed, the global energy problem can be partially relieved, deionized water is used as a solvent, the reaction condition is mild, the highest yield of the gamma valerolactone can reach 98%, and thus the prepared gamma valerolactone can be widely used as a green solvent, a biofuel and the like, and a new way is further provided for the utilization of renewable biomass energy.
Secondly, the invention uses cheap framework type copper-based metal alloy as the raw material of the catalyst, thereby avoiding the use of noble metal catalyst and saving the cost; in addition, the preparation process of the catalyst is simple.
Drawings
FIG. 1 is a GC-FID spectrum of gamma valerolactone according to example 1 of the invention.
Detailed Description
The invention provides gamma valerolactone and a method for preparing gamma valerolactone by utilizing levulinate.
The method for preparing gamma valerolactone by utilizing levulinate comprises the following steps:
reacting levulinic acid ester, a framework type copper-based metal alloy catalyst and deionized water under the condition of hydrogen at the temperature of 140-180 ℃ for 1-3 h; and carrying out solid-liquid separation after the reaction, collecting a liquid-phase product, and purifying to obtain gamma valerolactone.
The reaction route is as follows:
Figure BDA0002356865900000021
in particular, the amount of the solvent to be used,
Figure BDA0002356865900000031
firstly, both acetyl of ethyl levulinate and externally added H molecules are adsorbed on the surface of skeleton copper (Raney Cu), H attacks acetyl to form an extremely unstable gamma-hydroxyphenylanoic ester, and secondly, one molecule of ethanol is removed from the substance to obtain a target product gamma valerolactone.
When the pressure is less than 1MPa, the reaction is slower, and the yield of gamma valerolactone is too low; when the pressure is more than 5MPa, the yield of gamma valerolactone is not obviously improved. Therefore, the pressure of the hydrogen is 1-5 MPa.
When the temperature is lower than 140 ℃, the reaction is slower, and the yield of gamma valerolactone is too low; when the temperature is more than 180 ℃, the yield of gamma valerolactone is not obviously improved. Therefore, the reaction temperature is 140-180 ℃.
The framework type copper-based metal alloy catalyst is prepared by soaking copper-aluminum alloy in an aqueous solution of alkali. The temperature of the aqueous alkali solution may be 0-10 deg.C, and too high a temperature may result in a decrease in the specific surface area of the catalyst. The soaking time is 1.5-4.5 h.
The catalyst only contains copper element and aluminum element, and can selectively synthesize the gamma valerolactone.
The levulinic acid ester is selected from more than one of methyl levulinate, ethyl levulinate, propyl levulinate and butyl levulinate.
The gamma valerolactone is prepared by the method.
The present invention will be further described with reference to the following examples.
Example 1:
the method for preparing gamma valerolactone by using ethyl levulinate in the embodiment comprises the following steps:
sequentially putting 1mmol of ethyl levulinate, 50mg of framework type copper-based metal alloy catalyst and 10mL of deionized water into a 100mL closed reactor, filling 1MPa of hydrogen into the reactor, slowly discharging through a pressure reducing valve, repeatedly replacing air in the reactor for 3 times, filling 4MPa of hydrogen into the reactor, reacting for 3 hours at 160 ℃, taking out a solid-liquid mixture after reaction, separating and purifying to obtain a gamma valerolactone solution.
The product after the reaction was analyzed by GC-FID (see FIG. 1), which showed that the conversion of ethyl levulinate reached 93.6% while gamma valerolactone was the major product with a yield of 89.1%. The industrial application adopts a proper high-pressure reactor as required, the reaction temperature can be controlled to be 160 ℃, and the reaction lasts for 3 hours. By the reaction, the gamma valerolactone can be synthesized by taking ethyl levulinate as a raw material, the operation is simple and convenient, and the reaction selectivity is good.
Example 2:
the method for preparing gamma valerolactone by using ethyl levulinate in the embodiment comprises the following steps:
sequentially filling 1mmol of ethyl levulinate, 25mg of framework type copper-based metal alloy catalyst and 10mL of deionized water into a 100mL closed reactor, filling 1MPa of hydrogen into the reactor, slowly discharging through a pressure reducing valve, repeatedly replacing air in the reactor for 3 times, filling 4MPa of hydrogen into the reactor, reacting for 3 hours at 160 ℃, taking out a solid-liquid mixture after reaction, and separating to obtain a gamma valerolactone solution.
The products after the reaction were analyzed by GC-FID, which showed that the conversion of ethyl levulinate was 89.8%, whereas gamma valerolactone was the main product, with a yield of 83.9%. The industrial application adopts a proper high-pressure reactor as required, the reaction temperature can be controlled to be 160 ℃, and the reaction lasts for 3 hours. By the reaction, the gamma valerolactone can be synthesized by taking ethyl levulinate as a raw material, the operation is simple and convenient, and the reaction selectivity is good.
Example 3:
the method for preparing gamma valerolactone by using ethyl levulinate in the embodiment comprises the following steps:
sequentially filling 1mmol of ethyl levulinate, 100mg of framework type copper-based metal alloy catalyst and 10mL of deionized water into a 100mL closed reactor, filling 1MPa of hydrogen into the reactor, slowly discharging through a pressure reducing valve, repeatedly replacing air in the reactor for 3 times, filling 4MPa of hydrogen into the reactor, reacting for 3 hours at 160 ℃, taking out a solid-liquid mixture after reaction, and separating to obtain a gamma valerolactone solution.
After the reaction, the product was analyzed by GC-FID, and the GC-FID analysis showed that the conversion rate of ethyl levulinate reached 99.6%, while gamma valerolactone was the main product, with a yield of 98.3%. The industrial application adopts a proper high-pressure reactor as required, the reaction temperature can be controlled to be 160 ℃, and the reaction lasts for 3 hours. By the reaction, the gamma valerolactone can be synthesized by taking ethyl levulinate as a raw material, the operation is simple and convenient, and the reaction selectivity is good.
Example 4:
the method for preparing gamma valerolactone by using ethyl levulinate in the embodiment comprises the following steps:
sequentially filling 1mmol of ethyl levulinate, 100mg of framework type copper-based metal alloy catalyst and 10mL of deionized water into a 100mL closed reactor, filling 1MPa of hydrogen into the reactor, slowly discharging through a pressure reducing valve, repeatedly replacing air in the reactor for 3 times, filling 1MPa of hydrogen into the reactor, reacting for 3 hours at 160 ℃, taking out a solid-liquid mixture after reaction, and separating to obtain a gamma valerolactone solution.
The products after the reaction were analyzed by GC-FID, and the GC-FID analysis showed that the conversion of ethyl levulinate was 95.3%, while gamma valerolactone was the main product, with a yield of 82.4%. The industrial application adopts a proper high-pressure reactor as required, the reaction temperature can be controlled to be 160 ℃, and the reaction lasts for 3 hours. By the reaction, the gamma valerolactone can be synthesized by taking ethyl levulinate as a raw material, the operation is simple and convenient, and the reaction selectivity is good.
Example 5:
the method for preparing gamma valerolactone by using ethyl levulinate in the embodiment comprises the following steps:
sequentially filling 1mmol of ethyl levulinate, 100mg of framework type copper-based metal alloy catalyst and 10mL of deionized water into a 100mL closed reactor, filling 1MPa of hydrogen into the reactor, slowly discharging through a pressure reducing valve, repeatedly replacing air in the reactor for 3 times, filling 5MPa of hydrogen into the reactor, reacting for 3 hours at 160 ℃, taking out a solid-liquid mixture after reaction, and separating to obtain a gamma valerolactone solution.
After the reaction, the product was analyzed by GC-FID, and the GC-FID analysis showed that the conversion rate of ethyl levulinate reached 99.9%, while gamma valerolactone was the main product, with a yield of 98.0%. The industrial application adopts a proper high-pressure reactor as required, the reaction temperature can be controlled to be 160 ℃, and the reaction lasts for 3 hours. By the reaction, the gamma valerolactone can be synthesized by taking ethyl levulinate as a raw material, the operation is simple and convenient, and the reaction selectivity is good.
Example 6:
the method for preparing gamma valerolactone by using ethyl levulinate in the embodiment comprises the following steps:
sequentially filling 1mmol of ethyl levulinate, 100mg of framework type copper-based metal alloy catalyst and 10mL of deionized water into a 100mL closed reactor, filling 1MPa of hydrogen into the reactor, slowly discharging through a pressure reducing valve, repeatedly replacing air in the reactor for 3 times, filling 4MPa of hydrogen into the reactor, reacting for 3 hours at 140 ℃, taking out a solid-liquid mixture after reaction, and separating to obtain a gamma valerolactone solution.
The products after the reaction were analyzed by GC-FID, and the GC-FID analysis showed that the conversion of ethyl levulinate was 92.6%, while gamma valerolactone was the main product, with a yield of 72.3%. The industrial application adopts a proper high-pressure reactor as required, the reaction temperature can be controlled at 140 ℃, and the reaction lasts for 3 hours. By the reaction, the gamma valerolactone can be synthesized by taking ethyl levulinate as a raw material, the operation is simple and convenient, and the reaction selectivity is good.
Example 7:
the method for preparing gamma valerolactone by using ethyl levulinate in the embodiment comprises the following steps:
sequentially filling 1mmol of ethyl levulinate, 100mg of framework type copper-based metal alloy catalyst and 10mL of deionized water into a 100mL closed reactor, filling 1MPa of hydrogen into the reactor, slowly discharging through a pressure reducing valve, repeatedly replacing air in the reactor for 3 times, filling 4MPa of hydrogen into the reactor, reacting for 3 hours at 180 ℃, taking out a solid-liquid mixture after reaction, and separating to obtain a gamma valerolactone solution.
After the reaction, the product was analyzed by GC-FID, and the GC-FID analysis showed that the conversion rate of ethyl levulinate reached 99.3%, while gamma valerolactone was the main product, with a yield of 96.0%. In industrial application, a proper high-pressure reactor is adopted according to requirements, the reaction temperature can be controlled to be 180 ℃, and the reaction lasts for 3 hours. By the reaction, the gamma valerolactone can be synthesized by taking ethyl levulinate as a raw material, the operation is simple and convenient, and the reaction selectivity is good.
Example 8:
the method for preparing gamma valerolactone by using ethyl levulinate in the embodiment comprises the following steps:
sequentially filling 1mmol of ethyl levulinate, 100mg of framework type copper-based metal alloy catalyst and 10mL of deionized water into a 100mL closed reactor, filling 1MPa of hydrogen into the reactor, slowly discharging through a pressure reducing valve, repeatedly replacing air in the reactor for 3 times, filling 4MPa of hydrogen into the reactor, reacting for 1h at 160 ℃, taking out a solid-liquid mixture after reaction, and separating to obtain a gamma valerolactone solution.
The products after the reaction were analyzed by GC-FID, which showed that the conversion of ethyl levulinate was 83.0%, while gamma valerolactone was the main product, with a yield of 78.0%. The industrial application adopts a proper high-pressure reactor as required, the reaction temperature can be controlled to be 160 ℃, and the reaction lasts for 1 hour. By the reaction, the gamma valerolactone can be synthesized by taking ethyl levulinate as a raw material, the operation is simple and convenient, and the reaction selectivity is good.
The previous description of the disclosed embodiments is provided to enable any person skilled in the art to make or use the present invention. It will be readily apparent to those skilled in the art that various modifications to these embodiments and the generic principles defined herein may be applied to other embodiments without the use of the inventive faculty. Therefore, the present invention is not limited to the above-described embodiments. Those skilled in the art should appreciate that many modifications and variations are possible in light of the above teaching without departing from the scope of the invention.

Claims (8)

1. A method for preparing gamma valerolactone by utilizing levulinate ester is characterized in that: which comprises the following steps:
reacting levulinic acid ester, a framework type copper-based metal alloy catalyst and deionized water under the condition of hydrogen, carrying out solid-liquid separation after the reaction, collecting a liquid-phase product, and purifying to obtain gamma valerolactone;
the active components of the framework type copper-based metal alloy catalyst are copper and aluminum.
2. The method of claim 1, wherein: the framework type copper-based metal alloy catalyst is prepared by soaking copper-aluminum alloy in an aqueous solution of alkali;
the aqueous alkali solution is a 20 + -1 wt% aqueous sodium hydroxide solution.
3. The method of claim 2, wherein: the temperature of the aqueous alkali solution is 0-10 ℃.
4. The method of claim 2, wherein: the soaking time is 1.5-4.5 h.
5. The method of claim 1, wherein: the pressure of the hydrogen is 1-5 MPa.
6. The method of claim 1, wherein: the reaction temperature is 140-180 ℃, and the reaction time is 1-3 h.
7. The method of claim 1, wherein: the levulinic acid ester is selected from more than one of methyl levulinate, ethyl levulinate, propyl levulinate and butyl levulinate.
8. Gamma valerolactone, characterized by: prepared by the process of any one of claims 1 to 7.
CN202010010195.3A 2020-01-06 2020-01-06 Gamma valerolactone and method for preparing gamma valerolactone by utilizing levulinate Pending CN111153875A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010010195.3A CN111153875A (en) 2020-01-06 2020-01-06 Gamma valerolactone and method for preparing gamma valerolactone by utilizing levulinate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010010195.3A CN111153875A (en) 2020-01-06 2020-01-06 Gamma valerolactone and method for preparing gamma valerolactone by utilizing levulinate

Publications (1)

Publication Number Publication Date
CN111153875A true CN111153875A (en) 2020-05-15

Family

ID=70561512

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010010195.3A Pending CN111153875A (en) 2020-01-06 2020-01-06 Gamma valerolactone and method for preparing gamma valerolactone by utilizing levulinate

Country Status (1)

Country Link
CN (1) CN111153875A (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102617519A (en) * 2012-03-05 2012-08-01 中国石油大学(华东) Method for using levulinic acid to prepare gamma-valerolactone by hydrogenation
CN103012334A (en) * 2013-01-11 2013-04-03 中国科学技术大学 Method for preparing gamma-valerolactone with high selectivity under mild condition
US20130296579A1 (en) * 2012-03-07 2013-11-07 Council Of Scientific And Industrial Research PROCESS FOR PREPARATION OF gamma-VALEROLACTONE VIA CATALYTIC HYDROGENATION OF LEVULINIC ACID
JP2014166604A (en) * 2013-02-28 2014-09-11 Clariant Catalysts (Japan) Kk Hydrogenation catalyst of levulinic acid/ester, lactone synthesis reaction using the same, and lactone production facility
CN106349014A (en) * 2016-08-23 2017-01-25 上海交通大学 Method for preparing 1,4-pentanediol from levulinate ester
CN109485621A (en) * 2018-11-30 2019-03-19 中国科学技术大学 A method of producing gamma valerolactone

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102617519A (en) * 2012-03-05 2012-08-01 中国石油大学(华东) Method for using levulinic acid to prepare gamma-valerolactone by hydrogenation
US20130296579A1 (en) * 2012-03-07 2013-11-07 Council Of Scientific And Industrial Research PROCESS FOR PREPARATION OF gamma-VALEROLACTONE VIA CATALYTIC HYDROGENATION OF LEVULINIC ACID
CN103012334A (en) * 2013-01-11 2013-04-03 中国科学技术大学 Method for preparing gamma-valerolactone with high selectivity under mild condition
JP2014166604A (en) * 2013-02-28 2014-09-11 Clariant Catalysts (Japan) Kk Hydrogenation catalyst of levulinic acid/ester, lactone synthesis reaction using the same, and lactone production facility
CN106349014A (en) * 2016-08-23 2017-01-25 上海交通大学 Method for preparing 1,4-pentanediol from levulinate ester
CN109485621A (en) * 2018-11-30 2019-03-19 中国科学技术大学 A method of producing gamma valerolactone

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CHRISTOF AELLIG ET AL.: "Combined 1,4-butanediol lactonization and transfer hydrogenation/hydrogenolysis of furfural-derivatives under continuous flow conditions", 《CATAL. SCI. TECHNOL.》 *
DEZHANG REN ET AL.: "Selective hydrogenation of levulinate esters to 1,4-pentanediol using a ternary skeletal CuAlZn", 《GREEN CHEMISTRY》 *
任德章: "生物质基呋喃类/酯类平台化合物的催化转化及其机理研究", 《中国优秀博硕士学位论文全文数据库(博士)工程科技I辑》 *
景美波: "乙酰丙酸加氢制备γ-戊内酯催化剂及工艺研究", 《中国优秀博硕士学位论文全文数据库(硕士)工程科技I辑》 *

Similar Documents

Publication Publication Date Title
CN106349014B (en) Method for preparing 1, 4-pentanediol by utilizing levulinic acid ester
EP2668250B1 (en) Production of fuel from chemicals derived from biomass
CN104557801B (en) Method for preparing gamma-valerolactone from furfural on metal/solid acid catalyst
CN110092708B (en) Method for preparing ethanol by catalytic hydrogenation of lignocellulose
CN1762938A (en) Method for producing ethylene glycol and lower polyol using hydrocracking
JP2016041679A (en) Method for producing glucaric acid
CN109761938B (en) Method for catalyzing 5-hydroxymethylfurfural one-step reduction etherification
CN104650014A (en) Method for preparing methyl furoate by efficient catalytic oxidizing of furfural
CN111087370A (en) Method for preparing furfuryl alcohol by catalyzing furfural transfer hydrogenation through nitrogen-doped carbon loaded by non-noble metal
CN106540743A (en) A kind of catalyst that biological Aviation Fuel is prepared for jatropha oil and preparation method thereof
CN111153875A (en) Gamma valerolactone and method for preparing gamma valerolactone by utilizing levulinate
CN104844542A (en) Method for preparing gamma-valerolactone by levulinic acid ester without solvents
CN104788408A (en) Method for producing gamma-valerolactone from hemicellulose
CN109535108B (en) Preparation method of 2, 5-dimethylfuran
CN111116525B (en) 2, 5-dimethylfuran and method for preparing 2, 5-dimethylfuran by hydrogenation of 5-hydroxymethylfurfural
CN105693486A (en) Method for preparing 2,5-hexanedione and 3-methyl cyclopentenone from 5-hydroxymethyl furfural
CN114524706B (en) Method for preparing 2-butanol by catalytic hydrogenation of levulinic acid
CN111170935B (en) 3-hydroxypyridine and method for preparing 3-hydroxypyridine by using furfural
CN111041518A (en) Method for preparing valeric acid by electro-catalytic hydrogenation of levulinic acid
CN111116524A (en) Gamma valerolactone and method for preparing gamma valerolactone by utilizing levulinate
CN107325835B (en) Method for converting grease or higher fatty acid into long-chain alkane by hydrothermal method
CN1990456A (en) Method for production of N, N dimethyl cyclohexylamine
CN107417494A (en) The method that a kind of aliphatic acid original position hydrogenation prepares fatty alcohol
CN111434657B (en) Preparation method of gamma-valerolactone and levulinate ester compound
CN108947810B (en) Method for preparing succinic acid by carbonylation of acetylene

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20200515

RJ01 Rejection of invention patent application after publication